About Wayne Carter
Form D filings for Acenxion Biosytems from 2023 to 2024 list Wayne Carter as director.
Wayne Carter first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Wayne Carter in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Wayne Carter works with at each company, as listed on that company's latest Form D.
Acenxion Biosytems, Inc. · Form D, Aug 14, 2024
HG
Howard Goldstein
Director
BS
Brian Struchtemeyer
Executive officer and director
RS
Roy Swiger
CEO and director